-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
.
to effective treatment.
in regulating endoplasmic reticulum and mitochondrial calcium homeostasis under physiological and pathological conditions.
.
.
other pathophysiological processes.
.
previously unidentified pharmacological therapeutic targets for some human diseases.
is known about the channel.
.
.
by modulating mitochondrial physiology.
in the distribution of CLIC4 in the cytoplasm in the membrane components of heart failure patients and healthy heart organelles.
by which manganese chloride channels regulate multiple pathophysiological conditions.
2±0.
6%),
03) or neonatal cardiomyocytes (29±3%,
03,
to CLIC4 (Figure S1).
in MAMs.
1
of CLIC4.
of CLIC4 with mitochondria (row 1), ACSL4 (row 2), and mitochondria 2 (row 3).
showing commonalization quantification.
in the M3 fraction.
of CLIC4, GRP78 and ATP synthase normalized to total protein in different subcellular components by carmine S staining.
in purified mitochondria.
with the total protein content.
05, student's
.
associated with mam targeting.
of MAMs.
.
.
compared to wt.
.
.
.
。
01
.
of MAM-localized CLIC4 rather than ER-associated CLIC1 in regulating mPTP opening.
.
with the corresponding vehicle control group.
3%) were significantly lower than those in CsA group (130±7.
6%)
025
CLIC4.
infected with MNCMs.
.
obtained with a high dose of caffeine (10 mm).
。
05, student
.
.
.
After 5 min of recording, MNCMs undergo saponin penetration (SAP) prior to EGTA (2 mm) treatment to obtain minimal fluorescence followed by maximum fluorescence intensity
with Ca2+ (20 μM).
05, student
.
.
.
.
05, student
.
.
using Fluo-3 AM.
.
due to the RyR2 channel.
of the II+ ER/SR mitochondrial interface.
CLIC4 affects ER/SR mitochondrial
.
.
.
per group.
.
05, student
.
.
5 Hz pacing and recording the use of isoprenaline (ISO) (100 nm) with or without β-adrenergic receptor stimulation
.
.
.
03) compared with wild-type mice (28±3%,
in cardiac ischemic events.
sham surgery.
.
02,
CLIC4 is used to protect the heart from IR damage
.
sham control group, the mice did not develop any infarction.
.
in different experimental groups.
.
to wt mice.
.
of post-injury infarction by pseudo-infrared and ex vivo IR.
.
.
.
.
.
05
.
02
05
.
5±1.
3%) were significantly lower than wild-type (53.
8±2.
1%)
001
.
in CLIC4 expression in heart sections of permanent LCA-ligated mice and heart failure patients at 8 weeks.
01
of CLIC4 and CLIC1 in both exhausted and non-failing hearts.
to hearts without disease.
in the distribution of CLIC1 was observed.
in cardiac protection.
of CLIC4 at the cellular level independently of other cardiomyocyte environments.
4%,
05,
in determining the response of cardiomyocytes to HR injury.
05
4±0.
1-fold
1±0.
04-fold increase (
of CLIC4 in mediating cell protection in HR injury by regulating the opening of ROS and mPTP.
of cells from HR damage by regulating mitochondrial membrane potential and ROS levels.
.
.
.
OF TUNEL-POSITIVE CELLS.
as TUNEL-positive cell averages ± SEM.
05, using one-way ANOVA test and Newman-Keuls post-hoc analysis
.
under normal oxygen conditions.
under normogenic conditions.
of cardiomyocytes with wt-MNCMs after HR injury.
as mitochondrial membrane potential loss percentage mean ±SEM.
05, one-way ANOVA
using Newman-Keuls postmortal analysis.
to wt.
All data are expressed as averages ±SEM;
05, one-way ANOVA
using Newman-Keuls postmortal analysis.
of mom there.
to mediate endoplasmic reticulum-mitochondrial communication.
.
mitochondria.
to maintain the positioning of MAMs.
of CLIC4 in mouse cardiomyocytes.
.
.
.
of CLIC4 in regulating RyR2 activity in mouse cardiomyocytes.
to study the mechanism by which CLIC4 regulates RyR2 activity.
.
.
.
degree than WT.
This suggests the presence of another target of IAA-94 in the myocardial mitochondria that co-regulates CsA or
earlier than WT.
.
under physiological conditions.
.
left ventricular function.
mice versus wild-type mouse myocardial mitochondria in ex vivo IR injury.
of mPTP during stressful stimuli such as IR injury.
.
other CLICs protecting the heart from IR damage.
heart are mediated by targeting CLIC4.
Early CLIC1 is present in organelles within cells, such as ERs, lysosomes, and nuclei (
to injury.
by modulating mitochondrial physiology.
was observed in failing human hearts and mouse hearts suffering chronic myocardial injury (8-week LCA).
expression of CLIC4 associated with organelle membrane components in failing human hearts compared to healthy controls.
in the distribution of CLIC1 in heart failure heart tissue.
after HR injury.
mitochondrial membrane depolarization and cell death.
of MAM-CLIC4 in cardiomyocytes in protecting HR injury.
.
6
in cardiac protection by regulating mitochondrial function.
by the Ohio State University Board on Animal Care.
with the approval of The Ohio State University's Institutional Review Board.
.
in Dulbecco's modified Eagle medium (DMEM) containing 1 × glutamine, glucose (4.
5 g/L), 1 mM sodium pyruvate, sodium bicarbonate (1.
5 g/L), 10% (v/v) fetal bovine serum (FBS), and penicillin (100 IU)/streptomycin (100 μg/ml).
.
using the "quick exchange" legal point mutation method.
1-clic4 series
.
.
1 client 4
.
at 37 °C.
.
with Sanger sequencing.
13 mm thick) at a density of 15,000 cells and
.
as directed by the manufacturer.
.
.
.
5 mM NaH
8)] enter the right ventricle
.
Petri dish containing EDTA buffer.
5 mmNaH
8)], 30 ml collagenase solution [collagenase 2 (0.
5 mg/ml
5 mg/ml), and protease XIV prepared in perfusion buffer (0.
05 mg/ml)].
.
is inhibited with 5 ml of stop buffer [perfusion buffer containing 5% (v/v) sterile FBS].
by gravity.
at 4 °C.
.
.
8 mmna2HPO
4 mM glucose,
4 mM KCl and 0.
8 mM MgSO4
35)].
at 4 °C.
25% trypsin and incubate at 37 °C in a water bath shaker for 20 min for digestion
.
.
are observed.
1% (w/v)]–coated coverslips and cultured in DMEM containing 20% (v/v) FBS and penicillin (100 IU)/streptomycin (100 μg/ml), in 5% (v/v) humidified CO
after 2 days of incubation.
.
4)], using a Porter-Elviem homogenizer (seven-stroke).
.
at 4 °C.
.
.
.
4)]
。
.
.
Cover the resuspended crude mitochondrial preparation with 3 ml of 30% (v/v) Percoll
4)]
prepared in buffer B (250 mM sucrose, 10 mM Hepes Na, and 1 mM EDTA Na).
.
.
at 4 °C.
5% (w/v) sodium deoxycholate, 0.
1% (w/v) sodium lauryl sulfate, 1 mM NaF, 1 mM benzylsulfonyl fluoride and 1 mM Na
4) contains protease inhibitors (1 tablet/50 ml, Roche) and phosphatase inhibitors (1 tablet/10 ml, Roche)], frozen in liquid nitrogen, and processed for western blot analysis
.
5% (w/v) bovine serum albumin (BSA), 0.
5 mM EGTA, and 30 mM tris-HCl (pH 7.
4)) using
a Porter-Elviem homogenizer (8 strokes).
at 4 °C each.
at 4 °C.
5% (w/v) BSA, and 30 mM tris-HCl (pH 7.
4)) and hold at 10,000
at 4 °C.
4)], and centrifuge again at 10,000
at 4 °C.
mm5egta, 5 mMhepes (ph7.
4)].
4)] prepared in 30% (v/v) Percoll medium and held at 95,000
at 4 °C.
the MAM (upper band) and mitochondria (lower band).
at 4 °C.
in liquid nitrogen.
at 4 °C.
5 h
at 4 °C.
in liquid nitrogen.
.
glass coverslips.
at 400 Hz sample rate.
was observed with a confocal microscope.
.
.
were measured.
before recording.
with saponins [0.
001% (v/v)] before penetration.
.
3 μM, fluorescence is converted to [
。
RT recording.
at wavelengths of 500-530 nm.
at 10 mm.
.
200 Hz.
5 Hz
.
at 100 nm.
.
.
] with calcium di+ (54).
5 μM) (
prior to data acquisition.
at 20 V at 1 Hz.
.
after baseline and ISO treatment (100 nM).
7 mM KCl
2 mM KH) 2
2
1
。
.
after reperfusion with DMSO (vehicle control) or IAA-94 (50 μM).
.
After reperfusion, the heart is treated to evaluate mitochondrial colorectal cancer or stained with TTC to assess infarct area
.
Perform IR injury
.
within 2 minutes.
was done.
.
.
2-3 mm from the beginning of the left coronary artery with 6-0 silk thread.
is artificially expelled before the muscles and skin close.
8 cm
long.
the heart.
.
way to non-classical IR injury methods.
with saline-soaked gauze.
is closed after release.
.
of mice at basal level and 24 h after reperfusion.
.
.
.
perpendicular to the long axis of the heart.
.
with Leica S9i.
as a percentage of infarct area on AAR.
of the total area of the left ventricle.
.
, Toronto, Canada).
, Toronto) was used
.
5-2% (v/v) of isoflurane and O
.
.
using Vevo LAB 3.
1.
1 analysis software.
at 4 °C with continuous shaking.
.
.
nitrocellulose membrane.
with carmine S staining.
at 4 °C with various major antibodies.
05% Tween-20) for 10 min, culture with anti-rabbit/mouse secondary antibodies bound to IR680/IR800 for 1 h at room temperature, followed by three more washes with TTBS for 5 min
.
Observe the signal
using an infrared fluorescence system (Bio-Rad).
using the Lichun red S signal of different subcellular components.
.
.
1% (w/v) gelatin for 4 days, the cells were placed in a modular humidified hypoxic chamber (Biospherix, C127) and 1
.
.
.
.
5% (v/v) tritonx-100 for 10 min, followed by 30 min
with 10% normal goat serum (NGS).
at 4 °C with various specific primary antibodies [diluted in PBS containing 1% (w/v) NGS and 0.
1% (v/v) tritonx-100].
1% (v/v) Triton X-100 and incubated for 1 h at RT with secondary antibodies against rat/rabbit Alexa Fluor 488 (2 μg/ml) and anti-rabbit/mouse ATTO647N (1 μg/ml),
colocalization index.
was measured using chloromethyl 22′,7′-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) (Life Technologies, C26827).
at excitation and emission wavelengths of 485/535 nm with Nikon A1R confocal microscope.
similarly.
with ImageJ.
by a bar chart.
25% (v/v) Triton X-100 for 20 min, and stained
with TUNEL using the TUNEL assay kit as per the manufacturer's instructions (Thermo Fisher Scientific).
with DAPI counterstaining.
.
4)) using a Potter-Elvehjem homogenizer
(seven strokes).
.
Collect the supernatant and centrifuge at 12,000
1 mM EDTA, and 50 mM tris HCl (pH 7.
4)].
is detected with a fluorescence spectrophotometer (Hitachi F-2710 or Hitachi F-7100).
5 μM) (Thermo Fisher Scientific, extract 10 μl from a 500 μM stock) to CRC buffer [150 mM sucrose, 50 mM KCl, 2 mM KH2
4)], and fluorescence (500 nm excitation and 530 nm emission)
are measured.
.
.
of mitochondria using the Bio-Rad kit according to the manufacturer's instructions.
is compared.
.
with a Nikon A1R confocal microscope.
of mitochondrial membrane potential.
at 590 nm.
at 530 nm.
mitochondrial membrane potential.
using citrate buffer (Vector Laboratories, #H-3300-250).
.
.
.
at 4 °C with anti-CLIC4, anti-suppressin, and anti-cytochrome c antibodies.
1% (v/v) tritonx-100 containing PBS and then incubate with secondary antibodies
.
with Mowiol 4-88 or Extended Gold (molecular probe).
5 mM MgCl2
5) and complete protease inhibitor tablets], and restore isotonnity
by adding 100 μl of 2.
5 M sucrose.
at 4 °C.
25 M sucrose, and recentrifuge at 6,300
at 4 °C.
1% (v/v) NP-40 (pH 7.
5)] and homogenize (30 strokes).
.
.
.
.
.
with anti-CLIC1 and anti-CLIC4 antibodies.
was analyzed using ImageJ software.